HS

Hamsa Sandhya Rani

Active Director Director DIN 10085721
DIN 10085721 First appointment Mar 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Total affiliations 2 Since Mar 2023
Shareholding value •••• Premium profile

About Hamsa Sandhya Rani

Data last updated:

Hamsa Sandhya Rani is a Director at Innovative Pharma Solutions Private Limited (since 2024) and Director at V3s Life Sciences Private Limited (since 2023). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹3.03 Cr; the largest is Innovative Pharma Solutions Private Limited at ₹2.63 Cr (FY 2024).

DIN 10085721
Primary Designation Director
Industry Pharma
First Appointment 23 Mar 2023
Oldest Company Age 7 yrs
Largest company Innovative Pharma Solutions Private Limited · ₹2.63 Cr (FY 2024)
Combined revenue ₹3.03 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Dec 20242019₹2.63 Cr (FY 2024)Active
V3s Life Sciences Private Limited U46497TS2023PTC171337
Director23 Mar 20232023₹40.2 Lakh (FY 2024)Active

Board colleagues of Hamsa Sandhya Rani

Directorship timeline

Open interactive timeline →
V3s Life Sciences Private Limited
Innovative Pharma Solutions Private Limited
Premium access

Shareholding and investment profile for Hamsa Sandhya Rani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hamsa Sandhya Rani

Hamsa Sandhya Rani currently holds 2 directorships: Innovative Pharma Solutions Private Limited (Director, since 30 Dec 2024, revenue ₹2.63 Cr (FY 2024)); V3s Life Sciences Private Limited (Director, since 23 Mar 2023, revenue ₹40.2 Lakh (FY 2024)).

Hamsa Sandhya Rani was first appointed on 23 Mar 2023 as Director at V3s Life Sciences Private Limited. The most recent appointment on record is 30 Dec 2024 at Innovative Pharma Solutions Private Limited.

The 2 current companies of Hamsa Sandhya Rani that report revenue have a combined latest revenue of ₹3.03 Cr: Innovative Pharma Solutions Private Limited ₹2.63 Cr (FY 2024); V3s Life Sciences Private Limited ₹40.2 Lakh (FY 2024).

The current boards of Hamsa Sandhya Rani's companies include Vijaya Kumar Hamsa (Innovative Pharma Solutions Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available